Targeting SGLT2 inhibition in cardiology: what is the profile of benefit?

27 August 2018 (16:05 - 16:10)
Organised by:
Congress Presentation Part of: Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure Risk Factors and Prevention ESC Premium Access ESC Congress 2018